Cargando…

To study the effect of high dose Atorvastatin 40 mg versus 80 mg in patients with dyslipidemia

OBJECTIVE: Primary objective was to compare the effects of atorvastatin 40 mg vs 80 mg on LDL-C in Indian patients with atherosclerotic dyslipidemia. Secondary objectives were to compare the effects of atorvastatin 40 mg vs 80 mg on HDL-C and triglycerides and also comparing of side effects (myopath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agrawal, Deepak, Manchanda, S.C., Sawhney, J.P.S., Kandpal, Bhuwanesh, Jain, Rajneesh, Mehta, Ashwani, Mohanty, Arun, Passey, Rajiv, Makhija, Aman, Sharma, Manish Kr.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Clinical and Preventive Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6310693/ https://www.ncbi.nlm.nih.gov/pubmed/30595326 http://dx.doi.org/10.1016/j.ihj.2018.01.034

Ejemplares similares

Anemia profile in patients with congestive heart failure a hospital based observational study
por: Arora, Himanshu, et al.
Publicado: (2018)

Prevalence of familial hypercholesterolemia in premature coronary artery disease patients admitted to a tertiary care hospital in North India
por: Sawhney, J.P.S., et al.
Publicado: (2019)

Molecular studies in familial dilated cardiomyopathy – A pilot study
por: Mori, Vyom, et al.
Publicado: (2022)

Comparison of the Efficacy of Rosuvastatin 5 mg and 10 mg in Patients of Type 2 Diabetes Mellitus With Dyslipidemia
por: Aleem, Mudassar, et al.
Publicado: (2022)

Correlation of epicardial fat quantification with severity of coronary artery disease: A study in Indian population
por: Khurana, Rishabh, et al.
Publicado: (2018)

The Draupadi of dyslipidemia: Familial hypercholesterolemia
por: Kalra, Sanjay, et al.
Publicado: (2016)

Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction
por: Tunçez, Abdullah, et al.
Publicado: (2019)

Randomized controlled trial comparing the efficacy of daily and every other day atorvastatin therapy and its correlation with serum hydroxymethylglutaryl-CoA reductase enzyme levels in naïve dyslipidemic patients
por: Kumar, Manoj, et al.
Publicado: (2018)

Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study
por: Lee, Seung-Ah, et al.
Publicado: (2023)

Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
por: Constance, Christian, et al.
Publicado: (2014)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Markers in Acute Coronary Syndrome
por: Umrani, Salman, et al.
Publicado: (2020)

Preventive Effect of Atorvastatin (80 mg) on Contrast-Induced Nephropathy After Angiography in High-Risk Patients: Double-Blind Randomized Clinical Trial
por: Khosravi, Arezoo, et al.
Publicado: (2016)

Comparison of Atorvastatin and Rosuvastatin in Reduction of Inflammatory Biomarkers in Patients with Acute Coronary Syndrome
por: Kumar, Besham, et al.
Publicado: (2019)

Comparison of the efficacy and safety of rosuvastatin 10 mg and atorvastatin 20 mg in high-risk patients with hypercholesterolemia – Prospective study to evaluate the Use of Low doses of the Statins Atorvastatin and Rosuvastatin (PULSAR)
por: Clearfield, Michael B, et al.
Publicado: (2006)

The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years
por: Ben-Yehuda, Ori, et al.
Publicado: (2011)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry
por: Sawhney, Jitendra PS., et al.
Publicado: (2018)

Atorvastatin as a Rare Primary Cause of Drug-Induced Angioedema: A Case Report
por: Voloshyna, Diana, et al.
Publicado: (2022)

Prevalence of United States adults with triglycerides ≥ 135 mg/dL: NHANES 2007–2014
por: Fan, Wenjun, et al.
Publicado: (2019)

Berberine for Adjunct/Alternative Treatment of Dyslipidemia: A Literature Review
por: Evbayekha, Endurance O, et al.
Publicado: (2023)

ST2 elevation in heart failure, predictive of a high early mortality
por: Dalal, Jamshed J., et al.
Publicado: (2018)

Prevalence and real-world assessment of central aortic blood pressure in adult patients with essential hypertension uncontrolled on single anti-hypertensive agents
por: Sharma, Ranjan Kumar, et al.
Publicado: (2018)

Dyslipidemia and Associated Cardiovascular Risk Factors among Young Nepalese University Students
por: Nepal, Gaurav, et al.
Publicado: (2018)

Bempedoic Acid for Lipid Management in the Indian Population: An Expert Opinion
por: Hiremath, Jagdish, et al.
Publicado: (2023)

Bioavailability study of Enoxaparin Sodium Chemi (80 mg/0.8 mL) and Clexane (80 mg/0.8 mL) subcutaneous injection in healthy adults
por: Febbraro, Salvatore, et al.
Publicado: (2021)

Comparison of the effect of 40 and 80 mg/day doses of atorvastatin on changes in lipid profiles among acute coronary syndrome patients: A randomized clinical trial study
por: Sahebkar, Mohammad, et al.
Publicado: (2023)

Consensus statement on the management of dyslipidemia in Indian subjects: Our perspective
por: Bansal, Manish, et al.
Publicado: (2016)

Laser–Arc Hybrid Cladding of Al-Mg Alloy Coating on AZ80 Mg Alloy: Effect of Laser Beam Oscillations Amplitude
por: Ren, Zhiqiang, et al.
Publicado: (2022)

Patterns of Dyslipidemia Among Acute Coronary Syndrome (ACS) Patients at a Tertiary Care Hospital in Lahore, Pakistan
por: Muneeb, Muhammad, et al.
Publicado: (2022)

A Case Report of Secondary Postpartum Hemorrhage in a Pregnant Woman With a Mechanical Mitral Valve: Challenges of Anticoagulation
por: Singh Thakur, Aditi, et al.
Publicado: (2023)

Management of Stent Thrombosis Post-Percutaneous Coronary Intervention and Associated Rare Complications
por: Fadah, Kahtan, et al.
Publicado: (2021)

Comparison of Ezetimibe/Simvastatin 10/20 mg Versus Atorvastatin 20 mg in Achieving a Target Low Density Lipoprotein-Cholesterol Goal for Patients With Very High Risk
por: Cho, Yun-Kyeong, et al.
Publicado: (2011)

Myasthenia gravis: MuSK MG, late-onset MG and ocular MG
por: Deymeer, Feza
Publicado: (2020)

Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
por: Zheng, Dongdan, et al.
Publicado: (2015)

Synergistic effects of atorvastatin and rosiglitazone on endothelium protection in rats with dyslipidemia
por: Zhang, Wei-Li, et al.
Publicado: (2014)

Echocardiographic and Angiographic Assessment of Right Ventricular Function and Right Coronary Artery Stenosis in Acute Inferior Wall Myocardial Infarction
por: Kumar, Rajneesh, et al.
Publicado: (2023)

Efficacy and safety of standard dose triple combination of telmisartan 80 mg/amlodipine 5 mg/chlorthalidone 25 mg in primary hypertension: A randomized, double‐blind, active‐controlled, multicenter phase 3 trial
por: Cho, Eun Joo, et al.
Publicado: (2023)

Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study
por: Hing Ling, Paul Kah, et al.
Publicado: (2012)

Quadrupole Moments of $^{29}$Mg and $^{33}$Mg
por: Yordanov, Deyan Todorov, et al.
Publicado: (2019)

Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris
por: Pozdnyakov, Yuri M.
Publicado: (2018)

A combined experimental and computational study on the reaction of fluoroarenes with Mg–Mg, Mg–Zn, Mg–Al and Al–Zn bonds
por: Bakewell, Clare, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2ri93ouodi0c0gh5scvrlo1omi